Price to Book Value Chart

View Price to Book Value for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2006. Start Trial.
Date Value
August 21, 2026 1.162
August 20, 2026 1.131
August 19, 2026 1.226
August 18, 2026 1.131
August 17, 2026 1.134
August 14, 2026 1.127
August 13, 2026 1.092
August 12, 2026 1.148
August 11, 2026 1.120
August 10, 2026 1.057
August 07, 2026 1.057
August 06, 2026 1.046
August 05, 2026 1.036
August 04, 2026 1.057
August 03, 2026 1.060
July 31, 2026 1.025
July 30, 2026 1.053
July 29, 2026 1.011
July 28, 2026 1.011
July 27, 2026 0.9934
July 24, 2026 1.025
July 23, 2026 1.039
July 22, 2026 1.046
July 21, 2026 1.050
July 20, 2026 1.029
Date Value
July 17, 2026 1.053
July 16, 2026 1.039
July 15, 2026 1.134
July 14, 2026 1.074
July 13, 2026 1.088
July 10, 2026 1.060
July 09, 2026 1.117
July 08, 2026 1.194
July 07, 2026 1.205
July 06, 2026 1.272
July 02, 2026 1.279
July 01, 2026 1.219
June 30, 2026 1.201
June 29, 2026 1.165
June 26, 2026 0.9976
June 25, 2026 0.9845
June 24, 2026 0.9845
June 23, 2026 0.9845
June 22, 2026 1.001
June 18, 2026 0.9681
June 17, 2026 0.9779
June 16, 2026 0.9615
June 15, 2026 0.9648
June 12, 2026 0.9681
June 11, 2026 0.9747

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Anika Therapeutics, Inc. 2.077
MiMedx Group, Inc. 2.887
ABVC BioPharma, Inc. 2.115
Enovis Corp. 0.9846
Edwards Lifesciences Corp. 4.915

Price to Book Value Related Metrics

PS Ratio 724.81
PEG Ratio -5.758
Price 3.18
Earnings Yield -41.78%
Market Cap 362.79M
PEGY Ratio -5.758